Lixte Biotechnology Holdings Inc (LIXT)
2.89
+0.01
(+0.27%)
USD |
NASDAQ |
May 03, 16:00
2.89
0.00 (0.00%)
After-Hours: 20:00
Lixte Biotechnology Holdings Market Cap: 6.500M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 6.500M |
| May 02, 2024 | 6.483M |
| May 01, 2024 | 6.478M |
| April 30, 2024 | 6.208M |
| April 29, 2024 | 7.063M |
| April 26, 2024 | 7.333M |
| April 25, 2024 | 7.243M |
| April 24, 2024 | 7.378M |
| April 23, 2024 | 7.243M |
| April 22, 2024 | 7.535M |
| April 19, 2024 | 7.794M |
| April 18, 2024 | 7.537M |
| April 17, 2024 | 7.490M |
| April 16, 2024 | 7.873M |
| April 15, 2024 | 7.423M |
| April 12, 2024 | 7.828M |
| April 11, 2024 | 7.603M |
| April 10, 2024 | 7.558M |
| April 09, 2024 | 7.445M |
| April 08, 2024 | 7.445M |
| April 05, 2024 | 7.198M |
| April 04, 2024 | 7.693M |
| April 03, 2024 | 6.973M |
| April 02, 2024 | 8.322M |
| April 01, 2024 | 8.03M |
| Date | Value |
|---|---|
| March 28, 2024 | 7.603M |
| March 27, 2024 | 7.918M |
| March 26, 2024 | 5.072M |
| March 25, 2024 | 5.072M |
| March 22, 2024 | 4.950M |
| March 21, 2024 | 5.194M |
| March 20, 2024 | 5.196M |
| March 19, 2024 | 5.173M |
| March 18, 2024 | 5.511M |
| March 15, 2024 | 5.196M |
| March 14, 2024 | 5.106M |
| March 13, 2024 | 5.353M |
| March 12, 2024 | 5.308M |
| March 11, 2024 | 5.640M |
| March 08, 2024 | 5.466M |
| March 07, 2024 | 5.713M |
| March 06, 2024 | 5.443M |
| March 05, 2024 | 5.523M |
| March 04, 2024 | 5.556M |
| March 01, 2024 | 5.448M |
| February 29, 2024 | 5.848M |
| February 28, 2024 | 6.062M |
| February 27, 2024 | 6.006M |
| February 26, 2024 | 4.971M |
| February 23, 2024 | 4.993M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
3.891M
Minimum
Jan 18 2024
90.51M
Maximum
Aug 26 2019
34.26M
Average
26.94M
Median
Oct 04 2021
Market Cap Benchmarks
| iBio Inc | 6.934M |
| PAVmed Inc | 18.99M |
| PDS Biotechnology Corp | 140.11M |
| Moleculin Biotech Inc | 11.18M |
| Syros Pharmaceuticals Inc | 135.71M |
Market Cap Related Metrics
| Price to Book Value | 13.14 |
| Price | 2.89 |
| Earnings Yield | -93.43% |